You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

umbrella protocol

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Clinical Lactation Study on Exposure to Medicines Via Human Milk

Recruiting
  • Breast Feeding
  • Human Milk
  • Human milk collection
  • +2 more
  • Leuven, Vlaams-Brabant, Belgium
    Universitaire Ziekenhuizen KU Leuven
Sep 11, 2023

Umbrella Trial in Relapsed Small Cell Lung Cancer Patients

Recruiting
  • Small Cell Lung Cancers
  • No treatment is included in this protocol.
  • Seoul, Korea, Republic of
    Se-Hoon Lee
Aug 26, 2021

Glioblastoma, Adult Trial in Germany (APG101, Alectinib, Idasanutlin)

Recruiting
  • Glioblastoma, Adult
  • Berlin, Germany
  • +12 more
May 20, 2022

Premalignant Lesion, Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in France (Samples collection, Psychological and

Terminated
  • Premalignant Lesion
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Samples collection
  • +3 more
  • Annecy, France
  • +9 more
Oct 6, 2020

Plasma Cell Myeloma Refractory Trial in Worldwide (Isatuximab SAR650984, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma Refractory
  • Isatuximab SAR650984
  • +4 more
  • Chicago, Illinois
  • +18 more
Aug 2, 2022

Patients With Non-Small Cell Lung Cancer (NSCLC)

Completed
  • Lung Cancer
  • Tumor Biopsy
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 9, 2020

Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

Recruiting
  • Solid Tumor
  • Haematological Malignancy
  • Belfast, United Kingdom
  • +24 more
Jan 31, 2023

Cardiac Valve Disease Trial in Worldwide

Recruiting
  • Cardiac Valve Disease
    • New Orleans, Louisiana
    • +43 more
    Jan 31, 2023

    Survival of Genetically Modified White Blood Cells in

    Active, not recruiting
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 3, 2023

      Data Related to Patients With Cancer

      Not yet recruiting
      • Cancer
        • (no location specified)
        Aug 28, 2023

        Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

        Recruiting
        • Urothelial Carcinoma
        • Iowa City, Iowa
        • +11 more
        Dec 1, 2022

        Kidney Cancer Trial in Marseille (Radiologic Centralized Review, Tissue sample (tumor, sung, urine))

        Not yet recruiting
        • Kidney Cancer
        • Radiologic Centralized Review
        • Tissue sample (tumor, sung, urine)
        • Marseille, France
          Service d'Hématologie-Oncologie Pédiatrique - APHM
        Jun 28, 2019

        HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

        Completed
        • HNSCC
        • Head and Neck Neoplasms
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Mar 27, 2022

        Protocol For Collecting Data On Patients With Childhood Cancer

        Recruiting
        • Childhood Cancer
        • Data Collection
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Aug 22, 2022

        Initiative for Molecular Profiling in Advanced Cancer Therapy

        Unknown status
        • Advanced Cancers
        • Molecular Profiling Analyses
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        May 10, 2019

        Psychosis, Complex Post-Traumatic Stress Disorder, Schizophrenia Trial in Edinburgh, Glasgow (Affect Dysregulation intervention,

        Recruiting
        • Psychosis
        • +2 more
        • Affect Dysregulation intervention
        • +2 more
        • Edinburgh, United Kingdom
        • +1 more
        Mar 11, 2022

        Acquisition of Blood and Tumor Tissue Samples From

        Recruiting
        • Non-GI Cancers
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 28, 2023

          Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)

          Recruiting
          • Prostate Cancer
          • Apalutamide 60mg Tab
          • +5 more
          • Vancouver, British Columbia, Canada
          • +1 more
          May 25, 2022

          Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Chuo-ku, Tokyo, Japan
            National Cancer Center Hospital ( Site 3700)
          Jan 31, 2023

          Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,

          Recruiting
          • Esophageal Squamous Cell Carcinoma (ESCC)
          • Pembrolizumab
          • +5 more
          • Milan, Lombardia, Italy
          • +13 more
          Jan 3, 2023

          HIV Trial run by the NIAID (Interleukin-2)

          Completed
          • HIV Infections
          • Bethesda, Maryland
            NIH Intramural Research Program ACTG CRS
          Oct 28, 2021

          Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, Pembrolizumab/Quavonlimab)

          Recruiting
          • Melanoma
          • Pembrolizumab
          • +5 more
          • Los Angeles, California
          • +39 more
          Jan 25, 2023

          Cancer Metastatic Trial in Norway (Atezolizumab)

          Recruiting
          • Cancer Metastatic
          • Bergen, Norway
          • +16 more
          Oct 24, 2022

          Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

          Recruiting
          • Endometrial Cancer
          • Anchorage, Alaska
          • +78 more
          Jul 25, 2022